RI S2888

Licensed pharmacists may prescribe and dispense FDA-approved tobacco cessation drug therapies to patients aged 18+ who agree to participate in a structured cessation program with initial evaluation and follow-up visits

Pharmacists must complete tobacco cessation education approved by the state board of pharmacy and follow guidelines approved by the board, director of health, and director of behavioral healthcare

Pharmacists must notify the patient's primary care provider within 5 business days of prescribing a tobacco cessation product and must refer or consult with providers for high-risk patients or those with contraindications

All group health insurance policies issued or renewed on or after January 1, 2027 must cover pharmacist services within their lawful scope of practice, with insurers required to include pharmacists in their medical provider networks

Medicaid coverage for tobacco cessation drug therapies prescribed by pharmacists is contingent upon approval of a Section 1115 demonstration waiver